What did Advent International pay for PatientPoint?

Advent International acquired PatientPoint for $1.40B in 2025 (31.1x EBITDA). Target EBITDA was approximately $45.0M.

What does PatientPoint do?

PatientPoint is a healthcare it business.

What multiple did Advent International pay for PatientPoint?

31.1x EBITDA, based on disclosed deal value of $1.40B and disclosed financials.

M&A TRANSACTION · 2025

PatientPoint acquired by Advent International

$1.40B· 31.1x EBITDA

Target

PatientPoint

Acquirer

Advent International

Private Equity buyer

Disclosed financials at time of acquisition

Revenue

—

EBITDA

$45.0M

Deal Value

$1.40B

EV/EBITDA

31.1x

Context

This $1.40B acquisition of PatientPoint by Advent International sits in the healthcare it sub-vertical. The 31.1x EBITDA multiple paid in 2025 can be compared against the population median for healthcare it transactions of similar size on our Healthcare It valuation hub. Advent International is acquiring as a private equity buyer; see how PE acquirers typically price healthcare it businesses on our Healthcare It PE buyer-pool page.

Source

Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the PatientPoint acquisition.

Citation: ExitValue.ai. (2025). PatientPoint acquired by Advent International. https://exitvalue.ai/deals/patientpoint-acquired-by-advent-international-hc-2025-0007